
Physician-Scientist. Chief Research Officer @EngIPM. Gellert-John P. Leonard Scholar, Associate Professor @WeillCornell. Husband & father. RTs ≠ endorsements
Manhattan, NY
Joined February 2015
- Tweets13.3K
- Following8.7K
- Followers7.9K
- Likes90.2K
Pinned Tweet
Thank you to @CBSNews for highlighting our #research!
For many patients with muscle-invasive #BladderCancer, the standard of care is neoadjuvant systemic therapy followed by curative surgery to remove the bladder. For selected patients, bladder-preserving approaches are already an option, and the field is working to expand who can safely benefit.
Our #research at @WeillCornell @nyphospital combines patient-derived cancer organoids with AI to create “bio-digital avatars” of each patient's cancer.
This is team science, bringing together clinicians, laboratory scientists, computational biologists and mathematicians. We envision that these technologies could eventually help predict each patient’s response to treatment. Rigorous prospective validation will be essential before they can guide routine clinical care. @Cornell @WCMGUcancer @WCMEnglanderIPM @WCM_MeyerCancer @BladderCancerUS #FaltasLab
What if doctors could test cancer treatments on your tumor, without putting a single one of those treatments into your body? CBS News’ Riley Callanan reports.
How AI is revolutionizing cancer treatment
What if doctors could test cancer treatments on your tumor, without putting a single one of those treatments into your body? CBS News’ Riley Callanan reports.
Congratulations! Great work
My student Tony Cheng just published his PhD study (doi.org/10.1038/s41467-026-7…). He showed that homopolymers are great markers for retrospective lineage tracing, when you know how to reduce amplification and sequencing errors.
128
Dr. Bishoy M. Faltas retweeted
Now online: A Germline-Encoded lncRNA–Mitochondrial Axis Rewires Oxidative Phosphorylation to Drive Progression in Clear-Cell Renal Cell Carcinoma doi.org/10.1158/0008-5472.CA…
Dr. Bishoy M. Faltas retweeted
New preprint: RB1-null #prostate cancer is addicted to E2F, but E2Fs resist direct drugging. All six typical E2Fs share a conserved minor intron, so blocking the minor spliceosome mis-splices the whole family at once, downstream of RB where CDK4/6 fails. bit.ly/4zPoTDq
Nature research paper: A plant RNA-binding protein senses 2′,3′-cNMP produced by insect effectors
go.nature.com/4zMOuwE
Dr. Bishoy M. Faltas retweeted
Now online! Reconstructing developmental and disease progression with sample-level embeddings dlvr.it/TWGGs0
Nature research paper: An AI-native experimental laboratory for autonomous biomolecular operations
go.nature.com/47UJudb
Dr. Bishoy M. Faltas retweeted
Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype dlvr.it/TWGsF1
Dr. Bishoy M. Faltas retweeted
Now online: Tumor Cells Hijack Coagulation Signaling to Enable Immune Escape and Metastatic Dissemination doi.org/10.1158/0008-5472.CA…
Dr. Bishoy M. Faltas retweeted
How multimodal AI, combined with blood test omics via "liquid biopsies," will transform cancer monitoring and enable earliest detection.
open-access @CellCellPress
cell.com/cell/fulltext/S0092…
Dr. Bishoy M. Faltas retweeted
Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab dlvr.it/TWGGDQ
Honored to be featured in the Weill Cornell Hem/Onc 2026 newsletter as a @Regeneron Prize for Creative Innovation Finalist. Grateful to @WCMResearch and @HughHemmings for unwavering support, and to @FaltasLab, @DrScottTagawa, @ElementoLab, @DrDavidNanus for invaluable mentorship.
Dr. Bishoy M. Faltas retweeted
By analyzing a massive collection of #TCellReceptor chains from 150,000+ patient samples, researchers have developed a pipeline to accelerate the discovery and validation of public T cell receptors for immunotherapeutic design. @ScienceTM scim.ag/4zr7Ffb
Dr. Bishoy M. Faltas retweeted
Estimating the completeness of large-scale single-cell sequencing projects
nature.com/articles/s41467-0…
Nature research paper: In vivo CAR-T double knockout screen maps synergistic antitumour gene pairs
go.nature.com/48jt2U5
Dr. Bishoy M. Faltas retweeted
Physician Leadership in a Changing Healthcare Environment.
How can urology and oncology leaders drive innovation? @SWilliams_MD and @FaltasLab, discuss physician leadership in today's evolving healthcare environment. #Leadership #WatchNow > bit.ly/4dM6Cho @zklaassen_md
Dr. Bishoy M. Faltas retweeted
🌟Online now
@ednacukierman, Igor Astsaturov & co uncover that CAFs fuel pancreatic tumor growth and immune suppression by transferring membrane lipids to cancer cells through trogocytosis.
nature.com/articles/s43018-0…
Dr. Bishoy M. Faltas retweeted
Read about an AI agent assisting clinicians in assessing immune-related adverse events now in Nature Cancer!
@dbittermanmd
nature.com/articles/s43018-0…
Nature research paper: A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneity
go.nature.com/4kwQHr8
Dr. Bishoy M. Faltas retweeted
Excited to share our other recent paper in @NatureBiotech from Christina Leslie and our lab. We developed and in vivo validated DynaVelo, a deep learning tool that predicts rescue of genetic loss-of-function mutations. Brilliantly led by @karbalayghareh nature.com/articles/s41587-0…
Dr. Bishoy M. Faltas retweeted
Join or Renew Your ISUP Membership: isupweb.net/membership-join-…
📰 ISUP November 2026 Newsletter is out!
🔬 Stockholm Consensus Meeting highlights
🌍 Global outreach & new committees
📚 Education, mentorship & proficiency testing
🤝 Updates from CAP26 & IAP 2026
Read more: isupweb.net/isup-newsletter/

























